Apnex Medical™, Inc. was founded in 2006 with a mission to pioneer medical innovations to improve the health of people with sleep disordered breathing. Apnex is currently developing a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). This disorder is associated with significant long-term health problems. Current OSA treatments are not always successful and are often not well tolerated. The Apnex HGNS device is being designed to provide an alternative treatment for OSA that addresses these problems. 
Get Apnex Medical Clinical Study
and News Updates
Apnex Medical, Inc.
Information on the company, investors, newsroom, careers and opportunities.
Learn more...
Medical Professionals
For medical professionals interested in learning more about obstructive sleep apnea (OSA), Apnex HGNS Therapy, Apnex clinical research studies and OSA related medical meetings and publications.
Learn more...
Patients and Family Members
For people who are interested in learning more about OSA, Apnex HGNS Therapy and Apnex clinical research studies.
Learn more...
Company News Release
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Learn more...
Apnex in the News
News stories on Apnex Medical, Inc.
Learn more...

Apnex Medical™, Inc. | 2890 Centre Pointe Drive, St. Paul, MN 55113 USA | +1 651.757.4300 | info@apnexmedical.com
© Copyright 2010, Apnex Medical, Inc. All rights reserved. | Privacy Policy | Terms of Use

CAUTION: Apnex HGNS Device is an investigational device and is limited by Federal (or United States) law to investigational use. FOR CLINICAL TRIAL USE ONLY.